| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | Florida Pharmaceutical Products, LLC | INDOCO REMEDIES LIMITED | 20260527 | 3 |
| These highlights do not include all the information needed to use YUVEZZI™ safely and effectively. See full prescribing information for YUVEZZI. YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75% / 0.1%, for topical ophthalmic use Initial U.S. Approval: 2026 | Visus Therapeutics, Inc. | 20260527 | 4 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution 0.2%/0.5%, for topical ophthalmic use Initial U.S. Approval: 2007 | Glenmark Pharmaceuticals Inc., USA | SamChunDang Pharm Co, Ltd | 20260506 | 3 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For topical ophthalmic use Initial U.S. Approval: 2007 | Apotex Corp. | 20260423 | 7 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution 0.1%, for topical ophthalmic use Initial U.S. Approval: 1996 | Lifestar Pharma LLC | Mankind Pharma Limited | 20260417 | 5 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | NorthStar RxLLC | INDOCO REMEDIES LIMITED | 20260414 | 1 |
| Drug Facts | Bausch & Lomb Incorporated | Laboratoire Unither | 20260331 | 17 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE AND TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 2007 | Sandoz Inc | 20260331 | 16 |
| Lumify ® Preservative Free | Bausch & Lomb Incorporated | Laboratoire Unither | 20260317 | 9 |
| These highlights do not include all the information needed to use COMBIGAN safely and effectively. See full prescribing information for COMBIGAN. COMBIGAN ® (brimonidine tartrate and timolol maleate ophthalmic solution) 0.2%/0.5% , f or topical ophthalmic use Initial U.S. Approval: 2007 | Allergan, Inc. | 20260317 | 22 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution 0.1%, for topical ophthalmic use Initial U.S. Approval: 1996 | Gland Pharma Limited | 20260312 | 6 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.2% safely and effectively. See full prescribing information for Brimonidine tartrate ophthalmic solution, 0.2% Brimonidine tartrate ophthalmic solution, 0.2% For Topical Ophthalmic Use Initial U.S. Approval: 1996 | Florida Pharmaceutical Products, LLC | INDOCO REMEDIES LIMITED | Gland Pharma Limited | 20260128 | 4 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.15%, for topical ophthalmic use Initial U.S. Approval: 1996 | Sandoz Inc | 20251124 | 11 |
| These highlights do not include all the information needed to use Brimonidine Tartrate Ophthalmic Solution safely and effectively. See full prescribing information for Brimonidine Tartrate Ophthalmic Solution. Brimonidine Tartrate Ophthalmic Solution, 0.15% for topical ophthalmic use Initial U.S. Approval: 1996 | Apotex Corp. | Apotex Inc. | 20251008 | 7 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.1%, for topical ophthalmic use Initial U.S. Approval: 1996 | Sandoz Inc | 20251007 | 15 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION . BRIMONIDINE TARTRATE ophthalmic solution 0.1%, for topical ophthalmic use Initial U.S. Approval: 1996 | Apotex Corp. | 20250925 | 4 |
| These highlights do not include all the information needed to use ALPHAGAN P safely and effectively. See full prescribing information for ALPHAGAN P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% , for topical ophthalmic use Initial U.S. Approval: 1996 | Allergan, Inc. | 20250918 | 24 |
| These highlights do not include all the information needed to use Brimonidine tartrate ophthalmic solution 0.1% and 0.15% safely and effectively. See full prescribing information for brimonidine tartrate ophthalmic solution 0.1% and 0.15%. Brimonidine tartrate ophthalmic solution 0.1% and 0.15% Initial U.S. Approval: 1996 | Pacific Pharma, Inc. | 20250918 | 11 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2% safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2%. BRIMONIDINE TARTRATE ophthalmic solution 0.2%, for topical ophthalmic use Initial U.S. Approval: 1996 | Micro Labs Limited | 20250724 | 3 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution For Topical Ophthalmic Use Initial U.S. Approval: 1996 | Sandoz Inc | 20250530 | 7 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007 | Leading Pharma, LLC | Caplin Steriles Limited | 20250530 | 1 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. For Topical Administration Initial U.S. Approval: 2007 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited (F3) | 20250425 | 4 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE tartrate ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 1996 | Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited | 20250322 | 10 |
| These highlights do not include all the information needed to use SIMBRINZA ® safely and effectively. See full prescribing information for SIMBRINZA. SIMBRINZA ® (brinzolamide and brimonidine tartrate ophthalmic suspension) 1%/0.2%, for topical ophthalmic use Initial U.S. Approval: 2013 | Alcon Laboratories, Inc. | Alcon Research, LLC | S.A. Alcon-Couvreur N.V. | 20250311 | 19 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE/TIMOLOL MALEATE Ophthalmic Solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007 | Caplin Steriles Limited | 20250310 | 1 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | Upsher-Smith Laboratories, LLC | Rafarm S.A. | 20241108 | 5 |
| These highlights do not include all the information needed to use MIRVASO ® safely and effectively. See full prescribing information for MIRVASO. MIRVASO (brimonidine) topical gel Initial U.S. Approval: 1996 | Galderma Laboratories, L.P. | G Production Inc. | 20241024 | 11 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited | 20241014 | 3 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION BRIMONIDINE TARTRATE ophthalmic solution Initial U.S. Approval: 1996 | Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited | 20240826 | 4 |
| These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 1996 | Padagis Israel Pharmaceuticals Ltd | 20240731 | 4 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution For Topical Ophthalmic Use Initial U.S. Approval: 1996 | Bausch & Lomb Incorporated | 20240719 | 16 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION . BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution, for topical administration Initial U.S. Approval: 2007 | ARMAS PHARMACEUTICALS INC | SENTISS AG | Ophtapharm AG | 20231103 | 1 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE and TIMOLOL MALEATE ophthalmic solution. Brimonidine Tartrate and Timolol Maleate ophthalmic solution 0.2%/0.5% For Topical Administration Initial U.S. Approval: 2007. | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3) | 20230831 | 1 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE Ophthalmic Solution Initial U.S. Approval: 1996 | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3) | 20230828 | 1 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE Ophthalmic Solution Initial U.S. Approval: 1996 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited (F3) | 20230811 | 5 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution, 0.15% Initial U.S. Approval: 1996 | Alembic Pharmaceuticals Limited | Alembic Pharmaceuticals Limited (F3) | 20230706 | 1 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution, 0.15% Initial U.S. Approval: 1996 | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited (F3) | 20230404 | 3 |
| These highlights do not include all the information needed to use BRIMONIDINE TOPICAL GEL safely and effectively. See full prescribing information for BRIMONIDINE TOPICAL GEL . BRIMONIDINE topical gel Initial U.S. Approval: 1996 | Bryant Ranch Prepack | 20230203 | 100 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution, for topical ophthalmic use Initial U.S. Approval: 1996 | Akorn | 20220531 | 9 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION. BRIMONIDINE TARTRATE ophthalmic solution For Topical Ophthalmic Use Initial U.S. Approval: 1996 | A-S Medication Solutions | 20210616 | 6 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION 0.2% safely and effectively. See full prescribing information for Brimonidine Tartrate Ophthalmic Solution 0.2%. Brimonidine Tartrate Ophthalmic Solution 0.2% For Topical Ophthalmic Use Initial U.S. Approval: 1996 | A-S Medication Solutions | 20210211 | 6 |
| BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% | Sincerus Florida, LLC | 20190515 | 1 |
| BRIMONIDINE TARTRATE 0.25% / POTASSIUM AZELOYL DIGLYCINATE 8% | Sincerus Florida, LLC | 20190515 | 1 |
| These highlights do not include all the information needed to use BRIMONIDINE TARTRATE OPHTHALMIC SOLUTION, 0.2% safely and effectively. See full prescribing information for Brimonidine tartrate ophthalmic solution, 0.2% Brimonidine tartrate ophthalmic solution, 0.2% For Topical Ophthalmic Use Initial U.S. Approval: 1996 | Indoco Remedies Limited | 20181227 | 1 |
| 6ba4f0b3-d776-3485-e053-2991aa0abab3 | ImprimisRx NJ | 20180508 | 3 |
| 6bb49103-4a81-4cfc-e053-2991aa0a51ae | ImprimisRx NJ | 20180508 | 1 |
| 6bb58e03-7db3-23a2-e053-2a91aa0a8800 | ImprimisRx NJ | 20180508 | 1 |
| These highlights do not include all the information needed to use ALPHAGAN ® P safely and effectively. See full prescribing information for ALPHAGAN ® P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% Initial U.S. Approval: 1996 | Physicians Total Care, Inc. | 20130315 | 4 |
| Brimonidine Tartrate Ophthalmic Solution 0.2% (Sterile) | Physicians Total Care, Inc. | 20130219 | 2 |
| These highlights do not include all the information needed to use COMBIGAN ® safely and effectively. See full prescribing information for COMBIGAN ® . COMBIGAN ® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% Initial U.S. Approval: 2007 | Physicians Total Care, Inc. | 20110415 | 1 |
| bc1785c5-1448-4791-9868-2fbbc8703b3b | Physicians Total Care, Inc. | 20100112 | 1 |